GLP-1 receptor agonists were originally developed to lower blood sugar. What researchers discovered in subsequent cardiovascular outcome trials was something far more significant: these medications actively protect the heart, reduce the risk of stroke, and lower cardiovascular mortality — benefits that extend well beyond glucose control. The Landmark Cardiovascular Outcome Trials Trial Drug Key Finding…
GLP-1 receptor agonists produce impressive weight loss, but a significant proportion of that weight can come from muscle rather than fat. Understanding how to minimise muscle loss while on these medications is essential for long-term metabolic health and functional capacity. The Muscle Loss Problem Clinical trials show that approximately 25–40% of weight lost on GLP-1…
Retatrutide: A New Horizon in Diabetes and Obesity Management The global prevalence of type 2 diabetes and obesity continues to rise, posing significant health challenges and underscoring the urgent need for innovative and effective treatment strategies. For many individuals, managing these interconnected conditions involves a complex interplay of lifestyle modifications and pharmacological interventions. While existing…
Tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight management, represents a new class of medication that simultaneously activates two hormone receptors. Clinical trials have shown weight loss and blood sugar improvements that surpass anything previously seen in pharmaceutical treatment. What Makes Tirzepatide Different? Unlike semaglutide, which activates only the GLP-1 receptor, tirzepatide is…
GLP-1 receptor agonists have transformed diabetes and weight management, but their gastrointestinal side effects cause many people to reduce doses or discontinue treatment prematurely. Most side effects are manageable and tend to diminish over time. This guide explains what to expect and how to minimise discomfort. Why GLP-1 Medications Cause Side Effects GLP-1 receptor agonists…
Starting semaglutide? Here is a realistic week-by-week guide to your first month on Ozempic or Wegovy, covering what to expect with side effects, blood sugar changes, and weight loss.
Ozempic, Wegovy, and Mounjaro are three medications dominating conversations about diabetes and weight management. Here is a complete, evidence-based comparison to help you understand the differences.
For many years, getting a diagnosis of type 2 diabetes has felt like receiving a lifelong sentence. A health condition that, once it arrived, could only be managed, never cured. Most people learned to expect that diabetes would progress over time, with blood sugars creeping higher, medications piling up, and worries about complications always lurking…
In recent years, high-intensity interval training, better known as HIIT, has been drawing a lot of attention in public health circles, and for good reason. For people struggling with prediabetes or standing on the brink of type 2 diabetes, the idea that short, hard bursts of activity could actually reset key aspects of metabolic health…
Obesity isn’t just about weight. It’s driving serious health issues for millions of young adults — and it’s getting worse. A major study looked at global data from 1990 to 2019 and made predictions through 2050. The focus: adults aged 20 to 44. Here’s what you need to know. How Bad Is It Now? Obesity-related…
Urdu 
English